Literature DB >> 20089791

Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity.

Kimberly A Grove1, Joshua D Lambert.   

Abstract

Tea (Camellia sinensis, Theaceae) and tea polyphenols have been studied for the prevention of chronic diseases, including obesity. Obesity currently affects >20% of adults in the United States and is a risk factor for chronic diseases such as type II diabetes, cardiovascular disease, and cancer. Given this increasing public health concern, the use of dietary agents for the prevention of obesity would be of tremendous benefit. Whereas many laboratory studies have demonstrated the potential efficacy of green or black tea for the prevention of obesity, the underlying mechanisms remain unclear. The results of human intervention studies are mixed and the role of caffeine has not been clearly established. Finally, there is emerging evidence that high doses of tea polyphenols may have adverse side effects. Given that the results of scientific studies on dietary components, including tea polyphenols, are often translated into dietary supplements, understanding the potential toxicities of the tea polyphenols is critical to understanding their potential usefulness in preventing obesity. In this review, we will critically evaluate the evidence for the prevention of obesity by tea, discuss the relevance of proposed mechanisms in light of tea polyphenol bioavailability, and review the reports concerning the toxic effects of high doses of tea polyphenols and the implication that this has for the potential use of tea for the prevention of obesity. We hope that this review will expose areas for further study and encourage research on this important public health issue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089791      PMCID: PMC2821884          DOI: 10.3945/jn.109.115972

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  66 in total

1.  Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway.

Authors:  Hang-Seng Liu; Yen-Hang Chen; Pei-Fang Hung; Yung-Hsi Kao
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-09-13       Impact factor: 4.310

Review 2.  Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment.

Authors:  C Poitou Bernert; C Ciangura; M Coupaye; S Czernichow; J L Bouillot; A Basdevant
Journal:  Diabetes Metab       Date:  2007-01-26       Impact factor: 6.041

Review 3.  Orlistat-associated adverse effects and drug interactions: a critical review.

Authors:  Theodosios D Filippatos; Christos S Derdemezis; Irene F Gazi; Eleni S Nakou; Dimitri P Mikhailidis; Moses S Elisaf
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.

Authors:  H H Chow; Y Cai; D S Alberts; I Hakim; R Dorr; F Shahi; J A Crowell; C S Yang; Y Hara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-01       Impact factor: 4.254

5.  Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.

Authors:  H-H Sherry Chow; Iman A Hakim; Donna R Vining; James A Crowell; James Ranger-Moore; Wade M Chew; Catherine A Celaya; Steven R Rodney; Yukihiko Hara; David S Alberts
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

6.  Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies.

Authors:  R A Isbrucker; J A Edwards; E Wolz; A Davidovich; J Bausch
Journal:  Food Chem Toxicol       Date:  2006-01-04       Impact factor: 6.023

7.  The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase.

Authors:  Xuan Wang; Ke-Sheng Song; Qing-Xiang Guo; Wei-Xi Tian
Journal:  Biochem Pharmacol       Date:  2003-11-15       Impact factor: 5.858

8.  Analysis of theaflavins and thearubigins from black tea extract by MALDI-TOF mass spectrometry.

Authors:  Marie-Claude Menet; Shengmin Sang; Chung S Yang; Chi-Tang Ho; Robert T Rosen
Journal:  J Agric Food Chem       Date:  2004-05-05       Impact factor: 5.279

9.  The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.

Authors:  Mousumi Bose; Joshua D Lambert; Jihyeung Ju; Kenneth R Reuhl; Sue A Shapses; Chung S Yang
Journal:  J Nutr       Date:  2008-09       Impact factor: 4.798

10.  A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes.

Authors:  Tomonori Nagao; Shinichi Meguro; Tadashi Hase; Kazuhiro Otsuka; Masanori Komikado; Ichiro Tokimitsu; Takashi Yamamoto; Kunio Yamamoto
Journal:  Obesity (Silver Spring)       Date:  2008-11-13       Impact factor: 5.002

View more
  44 in total

1.  Tea consumption is inversely associated with weight status and other markers for metabolic syndrome in US adults.

Authors:  Jacqueline A Vernarelli; Joshua D Lambert
Journal:  Eur J Nutr       Date:  2012-07-10       Impact factor: 5.614

2.  A new method to prepare and redefine black tea thearubigins.

Authors:  Weixin Wang; Shuwei Zhang; Lishuang Lv; Shengmin Sang
Journal:  J Chromatogr A       Date:  2018-05-28       Impact factor: 4.759

Review 3.  Medicinal plants for the treatment of obesity: ethnopharmacological approach and chemical and biological studies.

Authors:  Luciano Mamede de Freitas Junior; Eduardo B de Almeida
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

4.  Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes.

Authors:  Marcela A Vazquez Prieto; Ahmed Bettaieb; Cecilia Rodriguez Lanzi; Verónica C Soto; Diahann J Perdicaro; Claudio R Galmarini; Fawaz G Haj; Roberto M Miatello; Patricia I Oteiza
Journal:  Mol Nutr Food Res       Date:  2015-03-11       Impact factor: 5.914

5.  Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAF-II cells.

Authors:  Lifeng Zhang; Eric Pang; Rachel R Ogorzalek Loo; Jianyu Rao; Vay-Liang W Go; Joseph A Loo; Qing-Yi Lu
Journal:  Proteomics       Date:  2011-11-23       Impact factor: 3.984

Review 6.  Weight control and prevention of metabolic syndrome by green tea.

Authors:  Sudathip Sae-tan; Kimberly A Grove; Joshua D Lambert
Journal:  Pharmacol Res       Date:  2010-12-28       Impact factor: 7.658

7.  Total and specific dietary polyphenol intakes and 6-year anthropometric changes in a middle-aged general population cohort.

Authors:  S Adriouch; E Kesse-Guyot; T Feuillet; M Touvier; V Olié; V Andreeva; S Hercberg; P Galan; L K Fezeu
Journal:  Int J Obes (Lond)       Date:  2017-09-20       Impact factor: 5.095

8.  Inhibition of pancreatic lipase by black tea theaflavins: Comparative enzymology and in silico modeling studies.

Authors:  Shannon L Glisan; Kimberly A Grove; Neela H Yennawar; Joshua D Lambert
Journal:  Food Chem       Date:  2016-08-18       Impact factor: 7.514

9.  Inhibition of starch digestion by the green tea polyphenol, (-)-epigallocatechin-3-gallate.

Authors:  Sarah C Forester; Yeyi Gu; Joshua D Lambert
Journal:  Mol Nutr Food Res       Date:  2012-10-05       Impact factor: 5.914

Review 10.  Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities.

Authors:  Yohei Shirakami; Masahito Shimizu; Masaya Kubota; Hiroshi Araki; Takuji Tanaka; Hisataka Moriwaki; Mitsuru Seishima
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.